White Coat Marketing: More unscrupulous behavior from the pharmaceutical industry
By Joe Messa
Novo Nordisk, a Danish pharmaceutical company focused on manufacturing medicinal treatments for diabetes, obesity, Haemophilia, growth hormone therapy, and hormone replacement therapy, has been accused in a lawsuit filed on behalf of the Federal Government of engaging in a “white coat marketing scheme” to persuade doctors to prescribe three of its diabetes treatments – NovoLog, […]
Continue reading